Amicus Therapeutics Inc. - Consensus EPS Growth Rate Next 5 Year - MarketXLS
Data
Consensus EPS Growth Rate Next 5 Year
Live45.2
Returns the analyst consensus estimate for EPS growth rate over the next 5 years.
How calculated | Estimated EPS growth for next 5 years as per analysts concensus |
Example usage | =EarningsEstimates_consensusEpsGrowthRate_next5year("MSFT") |
Notes | These are the estimates provided by the analysts for a particular stock and are subject to changes in the broader market conditions and the company performance. |
Assets | Stocks |
| Stock | Consensus EPS Growth Rate Next 5 Year |
|---|---|
FOLD | 45.2 |
BIIB | 6.4 |
ESPR | 39.5 |
BMRN | 41.0 |
Amicus Therapeutics Inc.
FOLD 
NSD
Sector: Healthcare
Industry: Biotechnology
9.50
USD
-0.09
(-0.94%)
Previous close: 9.59 Open: 9.62 Bid: 9.2 Ask: 9.79
52 week range
9.02 14.57
Mkt Cap: 2,845 M Avg Vol (90 Days): 2,373,271
Last updated: Friday 22nd November 2024
Call: 1-877-778-8358 
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.
I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.
MarketXLS is a complete Excel stock solution
I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel
MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.
I like to access historical closing prices on a particular date. That makes tracking performance easy.